These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36700630)

  • 1. Efficacy in Galleria mellonella Larvae and Application Potential Assessment of a New Bacteriophage BUCT700 Extensively Lyse Stenotrophomonas maltophilia.
    Li Y; Pu M; Han P; Li M; An X; Song L; Fan H; Chen Z; Tong Y
    Microbiol Spectr; 2023 Feb; 11(1):e0403022. PubMed ID: 36700630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae.
    Han P; Pu M; Li Y; Fan H; Tong Y
    Virol Sin; 2023 Oct; 38(5):801-812. PubMed ID: 37419417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and Comparative Genomics Analysis of a New Bacteriophage BUCT610 against
    Pu M; Han P; Zhang G; Liu Y; Li Y; Li F; Li M; An X; Song L; Chen Y; Fan H; Tong Y
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of phage evolution and phage resistance in drug-resistant
    Han P; Lin W; Fan H; Tong Y
    J Virol; 2024 Feb; 98(2):e0124923. PubMed ID: 38189285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and genome analysis of a novel Stenotrophomonas maltophilia bacteriophage BUCT598 with extreme pH resistance.
    Han K; He X; Fan H; Song L; An X; Li M; Tong Y
    Virus Res; 2022 Jun; 314():198751. PubMed ID: 35307481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of the novel bacteriophage vB_SmaS_BUCT626 against Stenotrophomonas maltophilia.
    Li F; Li L; Zhang Y; Bai S; Sun L; Guan J; Zhang W; Cui X; Feng J; Tong Y
    Virus Genes; 2022 Oct; 58(5):458-466. PubMed ID: 35633495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Novel Bacteriophages Improve Survival in
    Jeon J; Yong D
    Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential of Phage Therapy against the Emerging Opportunistic Pathogen
    McCutcheon JG; Dennis JJ
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34204897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and genomic characterization of a novel bacteriophage BUCT555 lysing Stenotrophomonas maltophilia.
    Han P; Hu Y; An X; Song L; Fan H; Tong Y
    Virus Res; 2021 Aug; 301():198465. PubMed ID: 34052250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of lytic activity of isolated phage and commercial Intesti bacteriophage on ESBL producer E. coli and determination of Ec_P6 phage efficacy with in vivo Galleria mellonella larvae model.
    Erol HB; Kaskatepe B; Ozturk S; Safi Oz Z
    Microb Pathog; 2022 Jun; 167():105563. PubMed ID: 35513294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage cocktail shows no toxicity and improves the survival of
    Kelly L; Jameson E
    J Virol; 2024 Jun; 98(6):e0027224. PubMed ID: 38771043
    [No Abstract]   [Full Text] [Related]  

  • 14. Genomic characterization of a new phage BUCT541 against
    Pu M; Li Y; Han P; Lin W; Geng R; Qu F; An X; Song L; Tong Y; Zhang S; Cai Z; Fan H
    Front Microbiol; 2022; 13():950737. PubMed ID: 36187954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential application of a newly isolated phage BUCT609 infecting
    Han K; Dong Y; An X; Song L; Li M; Fan H; Tong Y
    Front Microbiol; 2022; 13():1001237. PubMed ID: 36478859
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the Bacteriophage BUCT603 and Therapeutic Potential Evaluation Against Drug-Resistant
    Han P; Zhang W; Pu M; Li Y; Song L; An X; Li M; Li F; Zhang S; Fan H; Tong Y
    Front Microbiol; 2022; 13():906961. PubMed ID: 35865914
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterisation of Bacteriophage vB_SmaM_Ps15 Infective to
    Damnjanović D; Vázquez-Campos X; Elliott L; Willcox M; Bridge WJ
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Characterization of Type IV Pili as the Cellular Receptor of Broad Host Range
    McCutcheon JG; Peters DL; Dennis JJ
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29925793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Stenotrophomonas maltophilia temperate phage DLP4 is capable of lysogenic conversion.
    Peters DL; McCutcheon JG; Stothard P; Dennis JJ
    BMC Genomics; 2019 Apr; 20(1):300. PubMed ID: 30991961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to bacteriophage incurs a cost to virulence in drug-resistant
    Manley R; Fitch C; Francis V; Temperton I; Turner D; Fletcher J; Phil M; Michell S; Temperton B
    J Med Microbiol; 2024 May; 73(5):. PubMed ID: 38743467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.